Stem Cell Reviews and Reports

, Volume 13, Issue 4, pp 542–551 | Cite as

Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells

  • Morifumi Hanawa
  • Kazuo Takayama
  • Fuminori Sakurai
  • Masashi Tachibana
  • Hiroyuki Mizuguchi
Article

Abstract

Hepatocyte nuclear factor 4 alpha (HNF4α) is a key transcription factor for liver development. Although HNF4α is necessary for hepatoblast differentiation, the function of HNF4α before the hepatoblast differentiation, such as in definitive endoderm differentiation, is not well known. In addition, it is known that there are nine HNF4α isoforms, but the expression and function of each HNF4α isoform during the definitive endoderm differentiation is also not clear. In this study, we examined the expression pattern of HNF4α and its functions in the definitive endoderm differentiation from human induced pluripotent stem (iPS) cells. We found that the HNF4α-1D isoform expression levels were significantly increased during the definitive endoderm differentiation, while the HNF4α-1A isoform expression levels did not change. Therefore, we further examined the function of the HNF4α-1D isoform in definitive endoderm differentiation. HNF4α-1D overexpression or knockdown was found to promote or prevent the definitive endoderm differentiation, respectively. Interestingly, Lefty1 was directly regulated by HNF4α-1D, and Lefty1 knockdown also prevented the definitive endoderm differentiation. These results suggest that HNF4α-1D promotes definitive endoderm differentiation through the regulation of Lefty1. To our knowledge, this is the first report to clarify the expression pattern and function of HNF4α during the definitive endoderm differentiation.

Keywords

HNF4α Definitive endoderm Human iPS cells Lefty 1 Differentiation 

Notes

Acknowledgements

We thank Ms. Yasuko Hagihara, Ms. Natsumi Mimura, and Ms. Ayaka Sakamoto for their excellent technical support. This research was supported by the Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX), established by Human Resource Development Program for Science and Technology, MEXT. This research was also supported by the grants (15bk0104005h0003) from Japan Agency for Medical Research and development, AMED.

Compliance with Ethical Standards

Conflict of Interest

The authors declare no competing financial interests.

Supplementary material

12015_2016_9709_MOESM1_ESM.pdf (320 kb)
Figure S1 (PDF 319 kb)
12015_2016_9709_MOESM2_ESM.pdf (320 kb)
Figure S2 (PDF 320 kb)
12015_2016_9709_MOESM3_ESM.pdf (368 kb)
Figure S3 (PDF 367 kb)
12015_2016_9709_MOESM4_ESM.pdf (369 kb)
Figure S4 (PDF 368 kb)
12015_2016_9709_MOESM5_ESM.pdf (96 kb)
Figure S5 (PDF 96 kb)
12015_2016_9709_MOESM6_ESM.pdf (95 kb)
Figure S6 (PDF 95 kb)
12015_2016_9709_MOESM7_ESM.docx (14 kb)
Table S1 (DOCX 14 kb)
12015_2016_9709_MOESM8_ESM.docx (14 kb)
Table S2 (DOCX 13 kb)
12015_2016_9709_MOESM9_ESM.docx (14 kb)
Table S3 (DOCX 13 kb)

References

  1. 1.
    Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.CrossRefPubMedGoogle Scholar
  2. 2.
    Tsuneyoshi, N., Tan, E. K., Sadasivam, A., et al. (2012). The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells. Genes & Development, 26, 2471–2475.CrossRefGoogle Scholar
  3. 3.
    Si-Tayeb, K., Noto, F. K., Nagaoka, M., et al. (2010). Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells. Hepatology, 51, 297–305.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Teo, A. K. K., Arnold, S. J., Trotter, M. W. B., et al. (2011). Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes & Development, 25, 238–250.CrossRefGoogle Scholar
  5. 5.
    Watanabe, H., Takayama, K., Inamura, M., et al. (2014). HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PloS One, 9, e90791.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Duncan, S. A., Manova, K., Chen, W. S., et al. (1994). Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proceedings of the National Academy of Sciences of the United States of America, 91, 7598–7602.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Parviz, F., Matullo, C., Garrison, W. D., et al. (2003). Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nature Genetics, 34, 292–296.CrossRefPubMedGoogle Scholar
  8. 8.
    DeLaForest, A., Nagaoka, M., Si-Tayeb, K., et al. (2011). HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development, 138, 4143–4153.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Torres-Padilla, M. E., Fougere-Deschatrette, C., & Weiss, M. C. (2001). Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3′ end splicing. Mechanisms of Development, 109, 183–193.CrossRefPubMedGoogle Scholar
  10. 10.
    Takayama, K., Morisaki, Y., Kuno, S., et al. (2014). Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. PNAS, 111, 6.CrossRefGoogle Scholar
  11. 11.
    Miyoshi, H., Blomer, U., Takahashi, M., Gage, F., & Verma, I. M. (1998). Development of a self-inactivating lentivirus vector. Journal of Virology, 72, 8150–8157.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Mizuguchi, H., & Mark, A. K. (1988). Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Human Gene Therapy, 9, 7.Google Scholar
  13. 13.
    Mizuguchi, H., & Mark, A. K. A. (1999). Simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Human Gene Therapy, 10, 2013–2017.CrossRefPubMedGoogle Scholar
  14. 14.
    Motegi, Y., Katayama, K., Sakurai, F., et al. (2011). An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors. Journal of Controlled Release, 153, 149–153.CrossRefPubMedGoogle Scholar
  15. 15.
    Koizumi, N., Mizuguchi, H., Utoguchi, N., Watanabe, Y., & Hayakawa, T. (2003). Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob. The Journal of Gene Medicine, 5, 267–276.CrossRefPubMedGoogle Scholar
  16. 16.
    Tashiro, K., Kawabata, K., Sakurai, H., et al. (2008). Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. The Journal of Gene Medicine, 10, 498–507.CrossRefPubMedGoogle Scholar
  17. 17.
    Takayama, K., Inamura, M., Kawabata, K., et al. (2012). Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. Molecular Therapy, 20, 127–137.CrossRefGoogle Scholar
  18. 18.
    Tashiro, K., Inamura, M., Kawabata, K., et al. (2009). Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells, 27, 1802–1811.CrossRefPubMedGoogle Scholar
  19. 19.
    Maizel, J. V. J., White, D. O., & Scharff, D. M. (1968). The polypeptides of adenovirus: I. Evidence for mulltiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology, 36, 115–125.CrossRefPubMedGoogle Scholar
  20. 20.
    Kawabata, K., Sakurai, F., Yamaguchi, T., Hayakawa, T., & Mizuguchi, H. (2005). Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Molecular Therapy, 12, 547–554.CrossRefPubMedGoogle Scholar
  21. 21.
    Duncan, S. A., Nagy, A., & Chan, W. (1997). Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4-/- embryos. Development, 124, 279–287.PubMedGoogle Scholar
  22. 22.
    Bisgrove, B. W., Essner, J. J., & Yost, H. J. (1999). Regulation of midline development by antagonism of lefty and nodal signaling. Development, 126, 3253–3262.PubMedGoogle Scholar
  23. 23.
    Hamada, H., Meno, C., Watanabe, D., & Saijoh, Y. (2002). Establishment of vertebrate left–right asymmetry. Nature Reviews Genetics, 3, 103–113.CrossRefPubMedGoogle Scholar
  24. 24.
    Wang, H., & Tsang, B. K. (2007). Nodal signalling and apoptosis. Reproduction, 133, 847–853.CrossRefPubMedGoogle Scholar
  25. 25.
    Briancon, N., & Weiss, M. C. (2006). In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping. The EMBO Journal, 25, 1253–1262.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Wills Andrea, E., & Baker Julie, C. (2015). E2a is necessary for Smad2/3-dependent transcription and the direct repression of lefty during gastrulation. Developmental Cell, 32, 345–357.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Chou, W. C. (2002). Mechanism of a transcriptional cross talk between transforming growth factor-beta -regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. Molecular Biology of the Cell, 14, 1279–1294.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Morifumi Hanawa
    • 1
  • Kazuo Takayama
    • 1
    • 2
    • 3
    • 4
  • Fuminori Sakurai
    • 1
  • Masashi Tachibana
    • 1
  • Hiroyuki Mizuguchi
    • 1
    • 4
    • 5
    • 6
  1. 1.Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical SciencesOsaka UniversityOsakaJapan
  2. 2.The Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX)Kyoto UniversityKyotoJapan
  3. 3.PRESTO, Japan Science and Technology AgencySaitamaJapan
  4. 4.Laboratory of Hepatocyte Differentiation, National Institute of Biomedical Innovation, Health and NutritionOsakaJapan
  5. 5.iPS Cell-Based Research Project on Hepatic Toxicity and Metabolism, Graduate School of Pharmaceutical SciencesOsaka UniversityOsakaJapan
  6. 6.Global Center for Medical Engineering and InformaticsOsaka UniversityOsakaJapan

Personalised recommendations